In acute kidney injury, which renal replacement therapy modality—continuous renal replacement therapy or intermittent hemodialysis—is preferred based on the patient’s hemodynamic status?

Renal Replacement Therapy Selection in Acute Kidney Injury Based on Hemodynamic Status

In hemodynamically unstable patients with acute kidney injury, use continuous renal replacement therapy (CRRT) rather than intermittent hemodialysis (IHD). 1

Algorithmic Approach to RRT Modality Selection

Step 1: Assess Hemodynamic Stability

Hemodynamically UNSTABLE patients (requiring vasopressors, MAP instability, circulatory shock):

• Choose CRRT as the preferred modality 1
• KDIGO 2012 guideline recommendation 5.6.2: Grade 2B evidence supports CRRT over standard intermittent RRT
• CRRT provides better hemodynamic tolerance through slower, continuous fluid removal and reduced solute shifts 2

Hemodynamically STABLE patients:

• Either CRRT or IHD is acceptable 3
• The Surviving Sepsis Campaign 2016 states: "either continuous RRT or intermittent RRT be used" with moderate quality evidence
• No mortality difference exists between modalities in stable patients 3

Step 2: Consider Additional Clinical Factors

Use CRRT (not IHD) if ANY of the following are present:

• Acute brain injury or increased intracranial pressure 1
• Generalized brain edema 1
• Severe fluid overload requiring precise, gradual fluid removal 3
• Need for continuous fluid balance management 3

Use IHD (not CRRT) if:

• Life-threatening hyperkalemia requiring rapid correction (use high dialysate flow diffusive procedure) 4
• Severe metabolic acidosis requiring immediate correction 5, 6
• Patient is hemodynamically stable with standard dialysis indications

Step 3: Practical Implementation

For CRRT:

• Target effluent volume: 20-25 mL/kg/h 1
• Use regional citrate anticoagulation if no contraindications 1
• Provides slower solute shifts and better tolerance of fluid removal 2

For IHD:

• Target Kt/V of 3.9 per week (approximately 1.2-1.3 per session, 3 times weekly) 1
• Can be used if hemodynamics stable and no contraindications exist
• More efficient for rapid electrolyte correction

Critical Evidence Analysis

The evidence consistently shows no mortality difference between CRRT and IHD across multiple high-quality guidelines 3. The 2017 Surviving Sepsis Campaign reviewed five prospective RCTs and found no significant survival benefit for either modality. The most recent large RCT (360 patients) confirmed no mortality difference 3.

However, hemodynamic tolerance clearly favors CRRT in unstable patients. While only two prospective trials specifically demonstrated better hemodynamic tolerance with continuous treatment, the physiologic rationale is sound: slower fluid removal rates and continuous solute clearance minimize cardiovascular stress 3. Recent 2025 data confirms CRRT shows "improved hemodynamic tolerance" with "lower complication rates" compared to IHD 7.

Common Pitfalls to Avoid

1. Don't delay CRRT in unstable patients: Attempting IHD in hemodynamically unstable patients risks worsening hypotension and organ perfusion
2. Don't use CRRT for emergent hyperkalemia: IHD with high dialysate flow is superior for rapid potassium removal 4
3. Don't assume CRRT improves survival: Use CRRT for hemodynamic reasons, not mortality benefit 3
4. Don't forget to consider hybrid therapies: Sustained low-efficiency dialysis (SLED) or prolonged intermittent RRT can bridge the gap, offering 8-12 hour sessions with better hemodynamic tolerance than standard IHD 2

Nuanced Considerations

The 2021 ESPEN guideline notes that "only a few critically ill patients with AKI/AKD can tolerate the relatively short duration of treatments typical of conventional hemodialysis" 2. This reinforces that hemodynamic status is the primary determinant of modality choice.

View modalities as complementary, not competing 1, 6. Patients may transition between modalities as clinical status evolves. Consider switching from CRRT to IHD when vasopressor support stops and hemodynamics stabilize 8.